bosentan anhydrous has been researched along with Anemia, Sickle Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Berto-Junior, C; Guimarães-Nobre, CC; Mendonça-Reis, E; Miranda-Alves, L; Rosa Teixeira-Alves, L | 1 |
| Aractingi, S; Bachmeyer, C; Girot, R; Lionnet, F; Stankovic, K; Tharaux, PL | 1 |
| Coles, WA; Gladwin, MT; Kato, GJ; Machado, RF; Minniti, CP; Sachdev, V | 1 |
| Ataga, KI | 1 |
| Ataga, KI; Barst, RJ; Benza, RL; Castro, O; Gladwin, MT; Hildesheim, M; Machado, RF; Mubarak, KK; Naeije, R; Sood, N; Swerdlow, PS | 1 |
| Gerry Coghlan, J; Humbert, M; Khanna, D | 1 |
| Beuzard, Y; Bonnin, P; Castier, Y; de Franceschi, L; Debbabi, H; Dussaule, JC; Galaup, A; Germain, S; Girot, R; Henri, A; Janin, A; Leboeuf, C; Levy, B; Maier-Redelsperger, M; Malpeli, G; Sabaa, N; Scarpa, A; Tharaux, PL; Vandermeersch, S | 1 |
2 review(s) available for bosentan anhydrous and Anemia, Sickle Cell
| Article | Year |
|---|---|
Novel therapies in sickle cell disease.
Topics: Acute Chest Syndrome; Anemia, Sickle Cell; Anti-Inflammatory Agents; Anticoagulants; Bosentan; Child; Double-Blind Method; Drugs, Investigational; Erythrocytes; Fetal Hemoglobin; Humans; Immunoglobulins, Intravenous; Nitric Oxide; Plant Extracts; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfonamides | 2009 |
Early detection and management of pulmonary arterial hypertension.
Topics: Anemia, Sickle Cell; Antihypertensive Agents; Bosentan; Early Diagnosis; Echocardiography, Doppler; Exercise Test; Humans; Hypertension, Pulmonary; Mass Screening; Natriuretic Peptide, Brain; Peptide Fragments; Piperazines; Practice Guidelines as Topic; Purines; Respiratory Function Tests; Risk Factors; Scleroderma, Systemic; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2012 |
1 trial(s) available for bosentan anhydrous and Anemia, Sickle Cell
| Article | Year |
|---|---|
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.
Topics: Adult; Anemia, Sickle Cell; Antihypertensive Agents; Bosentan; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Artery; Sulfonamides; Vascular Resistance | 2010 |
4 other study(ies) available for bosentan anhydrous and Anemia, Sickle Cell
| Article | Year |
|---|---|
Bosentan attenuates sickle cell disease erythrocyte HbS polymerization and impaired deformability induced by endothelin-1.
Topics: Anemia, Sickle Cell; Bosentan; Endothelial Cells; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Erythrocyte Deformability; Erythrocytes; Humans; Polymerization; Receptors, Endothelin; Sulfonamides; Thrombospondins | 2023 |
Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers.
Topics: Anemia, Sickle Cell; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; Humans; Leg Ulcer; Middle Aged; Sulfonamides | 2008 |
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Drug Evaluation; Drug Therapy, Combination; Endothelin Receptor Antagonists; Exercise Test; Humans; Hypertension, Pulmonary; Middle Aged; Phenylpropionates; Piperazines; Purines; Pyridazines; Retrospective Studies; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome | 2009 |
Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.
Topics: Anemia, Sickle Cell; Animals; Antihypertensive Agents; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Humans; Hypoxia; Kidney; Lung; Mice; Mice, Inbred C57BL; Neutrophils; Receptors, Endothelin; Regional Blood Flow; Renal Circulation; Sulfonamides; Vasoconstriction | 2008 |